Enhancing natriuretic peptide signaling in adipose tissue, but not in muscle, protects against diet-induced obesity and insulin resistance

Science Signaling

Volumn 10, Issue 489, 2017, Pages

  Wu, Wei ^a,b   Shi, Fubiao ^a   Liu, Dianxin ^a   Ceddia, Ryan P ^a   Gaffin, Robert ^a   Wei, Wan ^a   Fang, Huafeng ^a   Lewandowski, E Douglas ^a   Collins, Sheila ^a  

^a BURNHAM INSTITUTE   (United States)

^b FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; NATRIURETIC FACTOR; ATRIAL NATRIURETIC FACTOR RECEPTOR; NATRIURETIC PEPTIDE RECEPTOR C;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BROWN ADIPOSE TISSUE; CONTROLLED STUDY; DIET INDUCED OBESITY; ENERGY EXPENDITURE; FATTY LIVER; GLUCOSE TRANSPORT; IN VIVO STUDY; INFLAMMATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAPERITONEAL FAT; LIPID DIET; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; ANIMAL; CHEMICALLY INDUCED; DRUG EFFECTS; FAT INTAKE; GENETICS; KNOCKOUT MOUSE; METABOLISM; OBESITY; PATHOLOGY; PHARMACOLOGY;

ADIPOSE TISSUE; ANIMALS; DIETARY FATS; INSULIN RESISTANCE; MICE; MICE, KNOCKOUT; OBESITY; RECEPTORS, ATRIAL NATRIURETIC FACTOR; SIGNAL TRANSDUCTION;

EID: 85026301714     PISSN: 19450877     EISSN: 19379145     Source Type: Journal    
DOI: 10.1126/scisignal.aam6870     Document Type: Article

References (58)

1. S. E. Kahn, R. L. Hull, K. M. Utzschneider, Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444, 840-846 (2006).
2. J. Park, D. M. Euhus, P. E. Scherer, Paracrine and endocrine effects of adipose tissue on cancer development and progression. Endocr. Rev. 32, 550-570 (2011).
3. N. E. Lepor, D. D. Fouchia, P. A. McCullough, New vistas for the treatment of obesity: Turning the tide against the leading cause of morbidity and cardiovascular mortality in the developed world. Rev. Cardiovasc. Med. 14, 20-39 (2013).
4. A. Guilherme, J. V. Virbasius, V. Puri, M. P. Czech, Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat. Rev. Mol. Cell Biol. 9, 367-377 (2008).
5. J. Nedergaard, T. Bengtsson, B. Cannon, Unexpected evidence for active brown adipose tissue in adult humans. Am. J. Physiol. Endocrinol. Metab. 293, E444-E452 (2007).
6. K. A. Virtanen, M. E. Lidell, J. Orava, M. Heglind, R. Westergren, T. Niemi, J. Laine, N.-J. Savisto, S. Enerbäck, P. Nuutila, Functional brown adipose tissue in healthy adults. N. Engl. J. Med. 360, 1518-1525 (2009).
7. N. Z. Jespersen, T. J. Larsen, L. Peijs, S. Daugaard, P. Homøe, A. Loft, J. de Jong, N. Mathur, B. Cannon, J. Nedergaard, B. K. Pedersen, K. Møller, C. Scheele, A classical brown adipose tissue mRNA signature partly overlaps with brite in the supraclavicular region of adult humans. Cell Metab. 17, 798-805 (2013).
8. A. M. Cypess, S. Lehman, G. Williams, I. Tal, D. Rodman, A. B. Goldfine, F. C. Kuo, E. L. Palmer, Y.-H. Tseng, A. Doria, A. B. Goldfine, G. M. Kolodny, C. R. Kahn, Identification and importance of brown adipose tissue in adult humans. N. Engl. J. Med. 360, 1509-1517 (2009).
9. W. D. van Marken Lichtenbelt, J. W. Vanhommerig, N. M. Smulders, J. M. A. F. L. Drossaerts, G. J. Kemerink, N. D. Bouvy, P. Scrauwen, G. J. Teule, Cold-activated brown adipose tissue in healthy men. N. Engl. J. Med. 360, 1500-1508 (2009).
10. T. G. Flynn, M. L. de Bold, A. J. de Bold, The amino acid sequence of an atrial peptide with potent diuretic and natriuretic properties. Biochem. Biophys. Res. Commun. 117, 859-865 (1983).
11. S. A. Waldman, R. M. Rapoport, F. Murad, Atrial natriuretic factor selectively activates particulate guanylate cyclase and elevates cyclic GMP in rat tissues. J. Biol. Chem. 259, 14332-14334 (1984).
12. M. Chinkers, D. L. Garbers, M.-S. Chang, D. G. Lowe, H. Chin, D. V. Goeddel, S. Schulz, A membrane form of guanylate cyclase is an atrial natriuretic peptide receptor. Nature 338, 78-83 (1989).
13. L. R. Potter, S. Abbey-Hosch, D. M. Dickey, Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions. Endocr. Rev. 27, 47-72 (2006).
14. R. Sarzani, P. Dessì-Fulgheri, V. M. Paci, E. Espinosa, A. Rappelli, Expression of natriuretic peptide receptors in human adipose and other tissues. J. Endocrinol. Invest. 19, 581-585 (1996).
15. C. Sengenès, M. Berlan, I. De Glisezinski, M. Lafontan, J. Galitzky, Natriuretic peptides: A new lipolytic pathway in human adipocytes. FASEB J. 14, 1345-1351 (2000).
16. M. Bordicchia, D. Liu, E.-Z. Amri, G. Ailhaud, P. Dessì-Fulgheri, C. Zhang, N. Takahashi, R. Sarzani, S. Collins, Cardiac natriuretic peptides act via p38 MAPK to induce the brown fat thermogenic program in mouse and human adipocytes. J. Clin. Invest. 122, 1022-1036 (2012).
17. A. L. Birkenfeld, M. Boschmann, C. Moro, F. Adams, K. Heusser, J. Tank, A. Diedrich, C. Schroeder, G. Franke, M. Berlan, F. C. Luft, M. Lafontan, J. Jordan, β-Adrenergic and atrial natriuretic peptide interactions on human cardiovascular and metabolic regulation. J. Clin. Endocrinol. Metab. 91, 5069-5075 (2006).
18. P. Dessi-Fulgheri, R. Sarzani, P. Tamburrini, A. Moraca, E. Espinosa, G. Cola, L. Giantomassi, A. Rappelli, Plasma atrial natriuretic peptide and natriuretic peptide receptor gene expression in adipose tissue of normotensive and hypertensive obese patients. J. Hypertens. 15, 1695-1698 (1997).
19. Z. Kovacova, W. G. Tharp, D. Liu, W. Wei, H. Xie, S. Collins, R. E. Pratley, Adipose tissue natriuretic peptide receptor expression is related to insulin sensitivity in obesity and diabetes. Obesity 24, 820-828 (2016).
20. M. Rydén, J. Bäckdahl, P. Petrus, A. Thorell, H. Gao, M. Coue, D. Langin, C. Moro, P. Arner, Impaired atrial natriuretic peptide-mediated lipolysis in obesity. Int. J. Obes. 40, 714-720 (2016).
21. A. Clerico, A. Giannoni, S. Vittorini, M. Emdin, The paradox of low BNP levels in obesity. Heart Fail. Rev. 17, 81-96 (2012).
22. C. Sengenès, A. Zakaroff-Girard, A. Moulin, M. Berlan, A. Bouloumié, M. Lafontan, J. Galitzky, Natriuretic peptide-dependent lipolysis in fat cells is a primate specificity. Am. J. Physiol. 283, R257-R265 (2002).
23. N. Matsukawa, W. J. Grzesik, N. Takahashi, K. N. Pandey, S. Pang, M. Yamauchi, O. Smithies, The natriuretic peptide clearance receptor locally modulates the physiological effects of the natriuretic peptide system. Proc. Natl. Acad. Sci. U.S.A. 96, 7403-7408 (1999).
24. A. L. Birkenfeld, M. Boschmann, C. Moro, F. Adams, K. Heusser, G. Franke, M. Berlan, F. C. Luft, M. Lafontan, J. Jordan, Lipid mobilization with physiological atrial natriuretic peptide concentrations in humans. J. Clin. Endocrinol. Metab. 90, 3622-3628 (2005).
25. A. L. Birkenfeld, P. Budziarek, M. Boschmann, C. Moro, F. Adams, G. Franke, M. Berlan, M. A. Marques, F. C. G. J. Sweep, F. C. Luft, M. Lafontan, J. Jordan, Atrial natriuretic peptide induces postprandial lipid oxidation in humans. Diabetes 57, 3199-3204 (2008).
26. K. Miyashita, H. Itoh, H. Tsujimoto, N. Tamura, Y. Fukunaga, M. Sone, K. Yamahara, D. Taura, M. Inuzuka, T. Sonoyama, K. Nakao, Natriuretic peptides/cGMP/cGMP-dependent protein kinase cascades promote muscle mitochondrial biogenesis and prevent obesity. Diabetes 58, 2880-2892 (2009).
27. S. Engeli, A. L. Birkenfeld, P.-M. Badin, V. Bourlier, K. Louche, N. Viguerie, C. Thalamas, E. Montastier, D. Larrouy, I. Harant, I. de Glisezinski, S. Lieske, J. Reinke, B. Beckmann, D. Langin, J. Jordan, C. Moro, Natriuretic peptides enhance the oxidative capacity of human skeletal muscle. J. Clin. Invest. 122, 4675-4679 (2012).
28. J. Jaubert, F. Jaubert, N. Martin, L. L. Washburn, B. K. Lee, E. M. Eicher, J.-L. Guénet, Three new allelic mouse mutations that cause skeletal overgrowth involve the natriuretic peptide receptor C gene (Npr3). Proc. Natl. Acad. Sci. U.S.A. 96, 10278-10283 (1999).
29. S. Li, M. P. Czubryt, J. McAnally, R. Bassel-Duby, J. A. Richardson, F. F. Wiebel, A. Nordheim, E. N. Olson, Requirement for serum response factor for skeletal muscle growth and maturation revealed by tissue-specific gene deletion in mice. Proc. Natl. Acad. Sci. U.S.A. 102, 1082-1087 (2005).
30. Z. V. Wang, Y. Deng, Q. A. Wang, K. Sun, P. E. Scherer, Identification and characterization of a promoter cassette conferring adipocyte-specific gene expression. Endocr inology 151, 2933-2939 (2010).
31. A. W. Ferrante Jr., Macrophages, fat, and the emergence of immunometabolism. J. Clin. Invest. 123, 4992-4993 (2013).
32. J. Banchereau, V. Pascual, A. O'Garra, From IL-2 to IL-37: The expanding spectrum of anti-inflammatory cytokines. Nat. Immunol. 13, 925-931 (2012).
33. K. Sun, J. Tordjman, K. Clément, P. E. Scherer, Fibrosis and adipose tissue dysfunction. Cell Metab. 18, 470-477 (2013).
34. R. Ye, P. E. Scherer, Adiponectin, driver or passenger on the road to insulin sensitivity? Mol. Metab. 2, 133-141 (2013).
35. K. Ohashi, J. L. Parker, N. Ouchi, A. Higuchi, J. A. Vita, N. Gokce, A. A. Pedersen, C. Kalthoff, S. Tullin, A. Sams, R. Summer, K. Walsh, Adiponectin promotes macrophage polarization toward an anti-inflammatory phenotype. J. Biol. Chem. 285, 6153-6130 (2010).
36. F. L. Martin, S. J. Sangaralingham, B. K. Huntley, P. M. McKie, T. Ichiki, H. H. Chen, J. Korinek, G. E. Harders, J. C. Burnett Jr., CD-NP: A novel engineered dual guanylyl cyclase activator with anti-fibrotic actions in the heart. PLOS ONE 7, e52422 (2012).
37. T. J. Wang, M. G. Larson, D. Levy, E. J. Benjamin, E. P. Leip, P. W. F. Wilson, R. S. Vasan, Impact of obesity on plasma natriuretic peptide levels. Circulation 109, 594-600 (2004).
38. O. Pivovarova, Ö. Gögebakan, N. Klöting, A. Sparwasser, M. O. Weickert, I. Haddad, V. J. Nikiforova, A. Bergmann, M. Kruse, A.-C. Seltmann, M. Blüher, A. F. H. Pfeiffer, N. Rudovich, Insulin up-regulates natriuretic peptide clearance receptor expression in the subcutaneous fat depot in obese subjects: A missing link between CVD risk and obesity? J. Clin. Endocrinol. Metab. 97, E731-E739 (2012).
39. S. R. Das, M. H. Drazner, D. L. Dries, G. L. Vega, H. G. Stanek, S. M. Abdullah, R. M. Canham, A. K. Chung, D. Leonard, F. H. Wians, J. A. de Lemos, Impact of body mass and body composition on circulating levels of natriuretic peptides: Results from the Dallas Heart Study. Circulation 112, 2163-2168 (2005).
40. M. Lafontan, C. Moro, M. Berlan, F. Crampes, C. Sengenes, J. Galitzky, Control of lipolysis by natriuretic peptides and cyclic GMP. Trends Endocrinol. Metab. 19, 130-137 (2008).
41. S. Collins, A heart-adipose tissue connection in the regulation of energy metabolism. Nat. Rev. Endocrinol. 10, 157-163 (2014).
42. D. K. Gupta, T. J. Wang, Natriuretic peptides and cardiometabolic health. Circ. J. 70, 1647-1655 (2015).
43. C. W. Liew, S. Xu, X. Wang, M. McCann, H. W. Kong, A. C. Carley, J. Pang, G. Fantuzzi, J. M. O'Donnell, E. D. Lewandowski, Multiphasic regulation of systemic and peripheral organ metabolic responses to cardiac hypertrophy. Circ. Heart Fail. 10, e003864 (2017).
44. W. L. Holland, A. C. Adams, J. T. Brozinick, H. H. Bui, Y. Miyauchi, C. M. Kusminski, S. M. Bauer, M. Wade, E. Singhal, C. C. Cheng, K. Volk, M.-S. Kuo, R. Gordillo, A. Kharitonenkov, P. E. Scherer, An FGF21-adiponectin-ceramide axis controls energy expenditure and insulin action in mice. Cell Metab. 17, 790-797 (2013).
45. Z. Lin, H. Tian, K. S. L. Lam, S. Lin, R. C. L. Hoo, M. Konishi, N. Itoh, Y. Wang, S. R. Bornstein, A. Xu, X. Li, Adiponectin mediates the metabolic effects of FGF21 on glucose homeostasis and insulin sensitivity in mice. Cell Metab. 17, 779-789 (2013).
46. G.-X. Wang, X.-Y. Zhao, Z.-X. Meng, M. Kern, A. Dietrich, Z. Chen, Z. Cozacov, D. Zhou, A. L. Okunade, X. Su, S. Li, M. Blüher, J. D. Lin, The brown fat-enriched secreted factor Nrg4 preserves metabolic homeostasis through attenuation of hepatic lipogenesis. Nat. Med. 20, 1436-1443 (2014).
47. A. J. Whittle, S. Carobbio, L. Martins, M. Slawik, E. Hondares, M. J. Vázquez, D. Morgan, R. I. Csikasz, R. Gallego, S. Rodriguez-Cuenca, M. Dale, S. Virtue, F. Villarroya, B. Cannon, K. Rahmouni, M. López, A. Vidal-Puig, BMP8B increases brown adipose tissue thermogenesis through both central and peripheral actions. Cell 149, 871-885 (2012).
48. T. Sonoyama, N. Tamura, K. Miyashita, K. Park, N. Oyamada, D. Taura, M. Inuzuka, Y. Fukunaga, M. Sone, K. Nakao, Inhibition of hepatic damage and liver fibrosis by brain natriuretic peptide. FEBS Lett. 583, 2067-2070 (2009).
49. N. Ishigaki, N. Yamamoto, H. Jin, K. Uchida, S. Terai, I. Sakaida, Continuos intravenous infusion of atrial natriuretic peptide (ANP) prevented liver fibrosis in rat. Biochem. Biophys. Res. Commun. 378, 354-359 (2009).
50. B. Haas, P. Mayer, K. Jennissen, D. Scholz, M. B. Diaz, W. Bloch, S. Herzig, R. Fässler, A. Pfeifer, Protein kinase G controls brown fat cell differentiation and mitochondrial biogenesis. Sci. Signal. 2, ra78 (2009).
51. M. M. Mitschke, L. S. Hoffmann, T. Gnad, D. Scholz, K. Kruithoff, P. Mayer, B. Haas, A. Sassmann, A. Pfeifer, A. Kilić, Increased cGMP promotes healthy expansion and browning of white adipose tissue. FASEB J. 27, 1621-1630 (2013).
52. J.-Y. Kim, E. van de Wall, M. Laplante, A. Azzara, M. E. Trujillo, S. M. Hofmann, T. Schraw, J. L. Durand, H. Li, G. Li, Linda A. Jelicks, M. F. Mehler, D. Y. Hui, Y. Deshaies, G. I. Shulman, Gary J. Schwartz, P. E. Scherer, Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J. Clin. Invest. 117, 2612-2637 (2007).
53. O. Osborn, J. M. Olefsky, The cellular and signaling networks linking the immune system and metabolism in disease. Nat. Med. 18, 363-374 (2012).
54. U. L. Aune, L. Ruiz, S. Kajimura, Isolation and differentiation of stromal vascular cells to beige/brite cells. J. Vis. Exp., e50191 (2013).
55. A. L. Birkenfeld, M. Boschmann, S. Engeli, C. Moro, A. M. Arafat, F. C. Luft, J. Jordan, Atrial natriuretic peptide and adiponectin interactions in man. PLOS ONE 7, e43238 (2012).
56. D. Liu, M. Bordicchia, C. Zhang, H. Fang, W. Wei, J.-L. Li, A. Guilherme, K. Guntur, M. P. Czech, S. Collins, Activation of mTORC1 is essential for β-adrenergic stimulation of adipose browning. J. Clin. Invest. 126, 1704-1716 (2016).
57. L. Lai, T. C. Leone, C. Zechner, P. J. Schaeffer, S. M. Kelly, D. P. Flanagan, D. M. Medeiros, A. Kovacs, D. P. Kelly, Transcriptional coactivators PGC-1α and PGC-1β control overlapping programs required for perinatal maturation of the heart. Genes Dev. 22, 1948-1961 (2008).
58. P. Pacher, T. Nagayama, P. Mukhopadhyay, S. Bátkai, D. A. Kass, Measurement of cardiac function using pressure-volume conductance catheter technique in mice and rats. Nat. Protoc. 3, 1422-1434 (2008).